MedTrace Logo

Angelman Syndrome Video Assessment (ASVA) Source Material Study

NCT05637697 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2023-12-13

No results posted yet for this study

Summary

This is a longitudinal, observational, nonrandomized, fully remote study enrolling approximately 55 participant-caregiver dyads. The study includes no treatments or interventions, and participants will not be asked to change their current treatments. The objective of this study is to gather sufficient source material videos to develop a scoring system for ASVA and to perform preliminary validation of that scoring system.

Conditions

Sponsors & Collaborators

  • Ionis Pharmaceuticals, Inc.

    collaborator INDUSTRY

  • Boston Children's Hospital

    collaborator OTHER

  • The Emmes Company, LLC

    lead INDUSTRY

Principal Investigators

  • Mindy Leffler · Casimir

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-31
Primary Completion
2023-08-01
Completion
2023-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05637697 on ClinicalTrials.gov